MedPath

Evaluation of the proportion of patients with indicated ASV therapy who can be shifted successfully to simple CPAP therapy after stabilization of respiration during primary ASV therapy

Not Applicable
Conditions
G47.39
Registration Number
DRKS00030283
Lead Sponsor
Helios Kliniken Schwerin
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
72
Inclusion Criteria

1. Indication for ASV therapy with AHI>15/h at best CPAP pressure
2. Central apnea/ hypopnea due to TECSA
3. Written informed consent to participate in the study, including a data protection statement.

Exclusion Criteria

1. Indication for NIV or o2 therapy
2. Presence of primary or exclusively central sleep apnea
3. Lack of written informed consent to participate in the study, including a data protection statement.
4. Presence of a contraindication to ASV therapy
5. Participation in another study influencing initiation of PAP therapy regarding device settings or tiration

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath